Skip to main content

4 Result(s)

within P. M. Schaffer Remove this filter

and

  1. No Access

    Article

    Treatment of astrocytoma grade III with Photofrin II as a radiosensitizer

    Astrocytomas are neoplasms that originate from glial cells. Anaplastic astrocytoma is classified as WHO III, with 27 % of the individuals with grade III astrocytoma living for at least 5 years even after treat...

    Prof. M. Schaffer MD PhD, A. Hofstetter, B. Ertl-Wagner… in Strahlentherapie und Onkologie (2013)

  2. No Access

    Article

    Application of Photofrin II as a specific radiosensitising agent in patients with bladder cancer—a report of two cases

    Background: the effect of ionizing radiation on tumour tissues can be optimised by adding radiosensitising agents to enhance tumour inactivation. Photofrin II has been approved as a photosensitising agent for ...

    M. Schaffer, P. M. Schaffer, M. Vogesser… in Photochemical & Photobiological Sciences (2002)

  3. No Access

    Chapter and Conference Paper

    Der Einfluß einer kombinierten Behandlung: Strahlentherapie und PDT, auf die Überlebenszeit des Ösophagus Karzinoms

    Die Chirurgische Intervention ist die empfehlenswerte Behandlungsmethode bei dem Öesophaguskarzinom.

    M. Schaffer, L. Corti, H. Hollenhorst, C. Bosso… in Laser in der Medizin Laser in Medicine (1998)

  4. No Access

    Chapter and Conference Paper

    Photodynamic Therapy of B16 Pigmented Melanoma with Si(IV)Naphthalocyanine Photoactivated by Diode Laser

    Melanotic malignant melanoma represents a major cause of death among skin neoplasias and its incidence is steadily increasing in Western world probably owing to changes in lifestyle which favour brief but inte...

    M. Schaffer, G. Jori, R. Biolo, P. M. Schaffer… in Laser in der Medizin / Laser in Medicine (1996)